Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome
Zlatan Mujagic, Melpomeni Kasapi, Daisy Jonkers, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Understanding neuroimmune interactions in disorders of gut–brain interaction: from functional to immune-mediated disorders
Tim Vanuytsel, Přemysl Berčík, Guy E. Boeckxstaens
Gut (2023) Vol. 72, Iss. 4, pp. 787-798
Open Access | Times Cited: 65
Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment
Kai-Yue Huang, Fengyun Wang, Mi Lv, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 26, pp. 4120-4135
Open Access | Times Cited: 45
The impact of acute and chronic stress on gastrointestinal physiology and function: a microbiota–gut–brain axis perspective
Sarah‐Jane Leigh, Friederike Uhlig, Lars Wilmes, et al.
The Journal of Physiology (2023) Vol. 601, Iss. 20, pp. 4491-4538
Open Access | Times Cited: 45
The gut microbiome in disorders of gut–brain interaction
Narjis Kraïmi, Taylor Ross, Julien Pujo, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Multifluid Metabolomics Identifies Novel Biomarkers for Irritable Bowel Syndrome
Daniel Kirk, Panayiotis Louca, Ilias Attaye, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 121-121
Open Access | Times Cited: 1
Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome
Qian Chen, Hua Zhang, Changyue Sun, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 20
Toward manipulating serotonin signaling via the microbiota–gut–brain axis
Blake A. Everett, Peter Tran, Arthur Prindle
Current Opinion in Biotechnology (2022) Vol. 78, pp. 102826-102826
Open Access | Times Cited: 24
“Sentinel or accomplice”: gut microbiota and microglia crosstalk in disorders of gut–brain interaction
Haonan Zheng, Cunzheng Zhang, Jindong Zhang, et al.
Protein & Cell (2023) Vol. 14, Iss. 10, pp. 726-742
Open Access | Times Cited: 14
Screening potential biomarkers associated with insulin resistance in high-fat diet-fed mice by integrating metagenomics and untargeted metabolomics
Yunyan Zhou, Jiahui Tang, Wei Du, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 4
The role of colonic microbiota amino acid metabolism in gut health regulation
Youli Chen, Jing‐Yuan Fang
Cell Insight (2025), pp. 100227-100227
Open Access
Microbial Influences on Irritable Bowel Syndrome
Eamonn M.M. Quigley
Gastroenterology Clinics of North America (2025)
Closed Access
Gut Microbiome-Liver-Brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches.
Emilio Merlo Pich, Ioannis Tarnanas, Patrizia Brigidi, et al.
Neurobiology of Stress (2025) Vol. 35, pp. 100713-100713
Open Access
A unified framework harnessing multi-scale feature ensemble and attention mechanism for gastric polyp and protrusion identification in gastroscope imaging
Chuqing He, Jiawan Zhang, Yunxiao Liang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Comparison of Rifaximin Monotherapy and Rifaximin Combined with Probiotics in Patients with Irritable Bowel Syndrome: A Randomized Controlled Trial
Chang Kyo Oh, Hwe Hoon Chung, Yu Jin Kim, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 763-763
Open Access
Impact of Demographic and Lifestyle Factors on Irritable Bowel Syndrome from Basra
Ziad Mansour, Dawood Salman Mahdi, Ihsan Edan Alsaimary
Journal of Biomedicine and Biochemistry (2025) Vol. 4, Iss. 1, pp. 52-58
Closed Access
Coffee and tea intake with long-term risk of irritable bowel syndrome: a large-scale prospective cohort study
Shanshan Wu, Zhirong Yang, Changzheng Yuan, et al.
International Journal of Epidemiology (2023) Vol. 52, Iss. 5, pp. 1459-1472
Open Access | Times Cited: 10
Change in the Gut Microbiome and Immunity by Lacticaseibacillusrhamnosus Probio-M9
Meng Zhang, Yan Zheng, Zheng Sun, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 8
Temporal stability of fecal metabolomic profiles in irritable bowel syndrome
Cristina Iribarren, Otto Savolainen, Maria Sapnara, et al.
Neurogastroenterology & Motility (2024) Vol. 36, Iss. 3
Open Access | Times Cited: 2
LAVASET: Latent Variable Stochastic Ensemble of Trees. An ensemble method for correlated datasets with spatial, spectral, and temporal dependencies
Melpomeni Kasapi, Kexin Xu, Timothy M. D. Ebbels, et al.
Bioinformatics (2024) Vol. 40, Iss. 3
Open Access | Times Cited: 2
Serotonin signaling to regulate energy metabolism:a gut microbiota perspective
Guoli Li, Sijing Dong, Chunhao Liu, et al.
Life Metabolism (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 2
Recent advances in data- and knowledge-driven approaches to explore primary microbial metabolism
Bartosz J. Bartmanski, Miguel Rocha, Maria Zimmermann‐Kogadeeva
Current Opinion in Chemical Biology (2023) Vol. 75, pp. 102324-102324
Open Access | Times Cited: 5
Small Intestinal Permeability and Metabolomic Profiles in Feces and Plasma Associate With Clinical Response in Patients With Active Psoriatic Arthritis Participating in a Fecal Microbiota Transplantation Trial: Exploratory Findings From the FLORA Trial
Maja Skov Kragsnæs, Jesús Miguéns Blanco, Benjamin H. Mullish, et al.
ACR Open Rheumatology (2023) Vol. 5, Iss. 11, pp. 583-593
Open Access | Times Cited: 5
Effect of gut microbiome on serotonin metabolism: a personalized treatment approach
Kristal Potter, Erysa J. Gayle, Subrata Deb
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2589-2602
Closed Access | Times Cited: 5
Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites
Jiahui Luan, Fuxin Zhang, Lijun Suo, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Multi-Omics Analysis of Gut Microbiota and Host Transcriptomics Reveal Dysregulated Immune Response and Metabolism in Young Adults with Irritable Bowel Syndrome
Jie Chen, Tingting Zhao, Hongfei Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3514-3514
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top